2018
DOI: 10.1111/cbdd.13439
|View full text |Cite
|
Sign up to set email alerts
|

Bisphosphonic acids and related compounds as inhibitors of nucleotide‐ and polyphosphate‐processing enzymes: A PPK1 and PPK2 case study

Abstract: Bisphosphonic acids, which are structural analogs of pyrophosphate, constitute a class of compounds with very high potential for the construction of effective inhibitors of enzymes operating on oligo‐ and polyphosphates. The bisphosphonate‐based methodology was applied for the discovery of inhibitors of two families of polyphosphate kinases (PPK1 and PPK2). Screening of thirty‐two structurally diverse bisphosphonic acids and related compounds revealed several micromolar inhibitors of both enzymes. Importantly,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 48 publications
0
6
0
Order By: Relevance
“…PPK knockout strains of pathogenic bacteria have long been known to harbor defects in stress response mechanisms and virulence factor pathways ( Fraley et al, 2007 ; Gangaiah et al, 2010 ; Chuang et al, 2013 ; Batten et al, 2016 ; Dahl et al, 2017 ). This decades old proof of concept has unsurprisingly enticed researchers to develop inhibitors targeting bacterial PPKs ( Singh et al, 2016 ; Dahl et al, 2017 ; Bashatwah et al, 2018 ; Burda-Grabowska et al, 2019 ). Although several inhibitors have been identified, these molecules suffer from their inability to selectively inhibit multiple PPK isoforms.…”
Section: Discussionmentioning
confidence: 99%
“…PPK knockout strains of pathogenic bacteria have long been known to harbor defects in stress response mechanisms and virulence factor pathways ( Fraley et al, 2007 ; Gangaiah et al, 2010 ; Chuang et al, 2013 ; Batten et al, 2016 ; Dahl et al, 2017 ). This decades old proof of concept has unsurprisingly enticed researchers to develop inhibitors targeting bacterial PPKs ( Singh et al, 2016 ; Dahl et al, 2017 ; Bashatwah et al, 2018 ; Burda-Grabowska et al, 2019 ). Although several inhibitors have been identified, these molecules suffer from their inability to selectively inhibit multiple PPK isoforms.…”
Section: Discussionmentioning
confidence: 99%
“…This screen identified the heteroaromatic compounds NSC 35676, NSC 30205, NSC 345647, and NSC 9037 as inhibitors of PPK2 at low-micromolar concentrations [ 55 ]. More recently, a series of (bis)phosphonic acid-derived PPK2 inhibitors have been developed [ 81 ]. Initially, three aryl phosphonate inhibitor molecules were co-crystallized with C. hutchinsonii PPK2, revealing the value of a (bis)phosphonate-based scaffold for PPK2 inhibition since this moiety was observed to competitively occupy the polyP channel [ 46 ].…”
Section: Therapeutic Potential: Ppk2 Inhibitorsmentioning
confidence: 99%
“…Several studies have focused on finding inhibitors of PPK (25,(41)(42)(43). One of the iden- SEMs (n = 4 independent experimental replicates).…”
Section: Sp15 Pmt3 Sp15 Pmt3mentioning
confidence: 99%